These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 28816643)

  • 21. Precision medicine for psychopharmacology: a general introduction.
    Shin C; Han C; Pae CU; Patkar AA
    Expert Rev Neurother; 2016 Jul; 16(7):831-9. PubMed ID: 27104961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research.
    Ahmed M; Semreen AM; El-Huneidi W; Bustanji Y; Abu-Gharbieh E; Alqudah MAY; Alhusban A; Shara M; Abuhelwa AY; Soares NC; Semreen MH; Alzoubi KH
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers and Immunotherapeutic Targets in Glioblastoma.
    Hung AL; Garzon-Muvdi T; Lim M
    World Neurosurg; 2017 Jun; 102():494-506. PubMed ID: 28300714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding and Treating Glioblastoma.
    Wick W; Platten M
    Neurol Clin; 2018 Aug; 36(3):485-499. PubMed ID: 30072067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
    Pecak M; Korošec P; Kunej T
    OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer.
    Judes G; Rifaï K; Daures M; Dubois L; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
    Cancer Lett; 2016 Nov; 382(1):77-85. PubMed ID: 26965997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Targeted therapy in glioblastoma: update and perspectives].
    Idbaih A; Duran-Peña A; Alentorn A
    Bull Acad Natl Med; 2015 Nov; 199(8-9):1323-1329. PubMed ID: 29874421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiomics for precision medicine in glioblastoma.
    Aftab K; Aamir FB; Mallick S; Mubarak F; Pope WB; Mikkelsen T; Rock JP; Enam SA
    J Neurooncol; 2022 Jan; 156(2):217-231. PubMed ID: 35020109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of Glioblastoma, Present and Future.
    Oberheim Bush NA; Hervey-Jumper SL; Berger MS
    World Neurosurg; 2019 Nov; 131():328-338. PubMed ID: 31658576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.
    Verduin M; Compter I; Steijvers D; Postma AA; Eekers DBP; Anten MM; Ackermans L; Ter Laan M; Leijenaar RTH; van de Weijer T; Tjan-Heijnen VCG; Hoeben A; Vooijs M
    Dis Markers; 2018; 2018():2908609. PubMed ID: 29581794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral Cancer: Genetics and the Role of Precision Medicine.
    Li CC; Shen Z; Bavarian R; Yang F; Bhattacharya A
    Surg Oncol Clin N Am; 2020 Jan; 29(1):127-144. PubMed ID: 31757309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. System-based approaches as prognostic tools for glioblastoma.
    Salvucci M; Zakaria Z; Carberry S; Tivnan A; Seifert V; Kögel D; Murphy BM; Prehn JHM
    BMC Cancer; 2019 Nov; 19(1):1092. PubMed ID: 31718568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
    Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
    Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One size should not fit all: advancing toward personalized glioblastoma therapy.
    Reardon DA; Ligon KL; Chiocca EA; Wen PY
    Discov Med; 2015 Jun; 19(107):471-7. PubMed ID: 26175405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individualizing Care: Management Beyond Medical Therapy.
    Cristoferi L; Nardi A; Invernizzi P; Mells G; Carbone M
    Surg Oncol Clin N Am; 2020 Jan; 29(1):87-103. PubMed ID: 31757316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translational Radiomics: Defining the Strategy Pipeline and Considerations for Application-Part 2: From Clinical Implementation to Enterprise.
    Shaikh F; Franc B; Allen E; Sala E; Awan O; Hendrata K; Halabi S; Mohiuddin S; Malik S; Hadley D; Shrestha R
    J Am Coll Radiol; 2018 Mar; 15(3 Pt B):543-549. PubMed ID: 29366598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacometabolomics informs Pharmacogenomics.
    Neavin D; Kaddurah-Daouk R; Weinshilboum R
    Metabolomics; 2016 Jul; 12(7):. PubMed ID: 27516730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacometabolomics Informs Viromics toward Precision Medicine.
    Balasopoulou A; Patrinos GP; Katsila T
    Front Pharmacol; 2016; 7():411. PubMed ID: 27833560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.